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To the Editor:
We congratulate Schaff and col-
leagues1 on their recent study. We
wish, however, to emphasize some
points that we believe they should
have taken into consideration.
We could not figure out how to
correlate the preoperatively used drug
with the survival rate (see original
Table 21). To agree with the results,
one should standardize the last echo-
cardiographic data of the lost patients
with those of the living patients. We
think that preoperative echocardio-
graphic status of the patient could not
be correlated with the survival of the
6th postoperative year. We could not
clearly understand whether it was pos-
tulated that thewall thickness of 22mm
(see original Figure 41) did not have an
impact on survival or whether one
would bring the survival to an expected
level with the use of drugs? We thinkThe Journalthat the original Figure 2 is in contra-
diction with the original Figure 4.1
Ommen and associates2 previ-
ously stated that the pressure gradi-
ent does not have an impact on
(cardiac) survival because their mor-
tality was also 6% in the nonob-
structive group. Nevertheless, there
was limited information because of
the lack of postoperative echocar-
diographic data in the myectomy
group with respect to postoperative
pressure gradient, wall thickness,
and left ventricular diameters.
The standardization of the groups
after inclusion of the final echocardio-
graphic data of the lost patients would
yield the definitive results of this
study.
Mert Kestelli, MD
Ismail Yurekli, MD
Mehmet Bademci
Izmir Ataturk Education and
Research Hospital
Izmir, Turkey
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TREATMENT FOR INFECTIVE
ENDOCARDITIS: DOES IT
COME AT THE EXPENSE OF
WORSE NEUROLOGIC
OUTCOMES?
To the Editor:
With much interest we read the
recent article of Funakoshi and col-
leagues,1 suggesting superior long-
term outcomes for patients with
infective endocarditis after early sur-
gical treatment relative to a purported
conventional treatment strategy.of Thoracic and Cardiovascular SurgerAlthough the results seem in line
with general consensus, several meth-
odologic issues arise, affecting the
validity of the study’s conclusions.
First, we would like to comment on
the definition of the study groups. The
conventional treatment group includes
patientswho have been treatedwith an-
tibiotics only, as well as patients who
have been operated on at a later stage.
In our opinion, these patients should
not be combined into a single treatment
group. To illustrate this, the in-hospital
mortality is 5% for both the early and
late surgical groups. On the other
hand, the mortality of the conventional
treatment group seems higher (5% vs
13%; P¼ .08), possibly caused by un-
favorable results in the nonsurgical
group. It would have been more infor-
mative to have 3 groups for compari-
son: patients after early surgical
treatment, patients after late surgical
treatment, and patients who have
been treated with antibiotics only.
Correspondingly, it is problematic to
interpret the result of the propensity-
matched comparison, because it re-
mains unclear how many patients in
the conventional treatment group have
undergone surgical treatment. To as-
sess the role of early surgical treatment
in infective endocarditis adequately, it
would be more instructive to compare
the results of early surgical treatment
with those of late surgical treatment.
Second, the chosen period of
14 days after the initial diagnosis as
cutoff point for early versus late
surgery seems questionable. Several
studies show that the risk of embolic
events dramatically drops as early as
1 week of antibiotic treatment.2 Ac-
cordingly, the European guidelines3
on this specific subject advise that
early surgical treatment should be per-
formed within several days after the
diagnosis, instead of after 14 days,
whenever there is an indication for
early operation.
Another point of concern is the
postoperative neurologic outcome.
Among patients who had complicat-
ing stroke on admission, 30% hady c Volume 144, Number 6 1537
Letters to the Editoreither cerebral infarction or hemor-
rhage after early surgical treatment,
compared with 8% in the late opera-
tion group. Facing these results, one
should keep in mind the recommenda-
tions by the Society of Thoracic
Surgeons Clinical Practice Guide-
lines4 to delay surgery for at least
4 weeks if possible for patients who
have had a major ischemic stroke or
any intracranial hemorrhage.
Finally, we are interested in the
results of intraoperative valve cultures
and pathologic examination of in-
fected valves. How many patients
showed traces of active endocarditis
during surgery? Was this associated
with the fairly high risk of reoperation
during follow-up (9%-12%)?
In conclusion, we could say that this
study shows a lower in-hospital mor-
tality in the early surgery group at the
expense of worse neurologic out-
comes. We think that if one does not
know the indications for early surgery,
a judgment on the outcomes of surgery
will be questionable. Referring to
these concerns, we consider the data
presented not convincing for dropping
a patient-tailored approach in favor of
a priori early surgical treatment.
Henryk Jan te Kolste, MD
Wilson Wan Lung Li, MD
Bas A. J. M. de Mol, MD, PhD
Cardiothoracic Surgery
Academic Medical Center
Amsterdam, The Netherlands
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j.jtcvs.2012.03.090RESCUE CORONARYARTERY
BYPASSGRAFTINGINISOLATED
LIFE-THREATENING RIGHT
VENTRICULAR FAILURE AFTER
AORTIC VALVE REPLACEMENT
To the Editor:
Coronary ostial damage is a rare but
potentially serious sequela after aortic
valve replacement. It occurs in the left
main or right coronary artery after 1%
to 5% of aortic valve replacement pro-
cedures.This lethal conditionmaypres-
ent with difficulty in weaning from
cardiopulmonary bypass pump; echo-
cardiographic signs of major wall
motion abnormalities; or electrocardio-
graphic evidence of ischemia, pump
failure, and ventricular arrhythmias.
The outcomes are usually severe and
may appear immediately during sur-
gery. The typical treatment in
operating is coronary artery bypass
grafting.1
Here we present the case of a patient
with bicuspid aortic valve and severe
aortic stenosis who underwent Man-
aguan surgery associated with aortic
valve replacement with a 23-mm diam-
etermechanical valve (St JudeMedical,
Inc, St Paul, Minn), and cardioplegic
solution was administered antegradely.
Right ventricular failure unexpectedly
occurred in the operating room after
aortic valve replacement, and the pa-
tient could not be separated from the
cardiopulmonary bypass pump. This
problem was not resolved by medica-
tion. Intraoperative transesophageal
echocardiography showed a well-
functioning mechanical prosthesis
with no evidence of paravalvular leak-
age, air emboli, interfering mechanical
aortic valve with the ostial rightCardiovascular Surgery c December 20coronary artery or any regional wall
motion abnormality. Intraoperative
transesophageal echocardiography re-
vealed severe right ventricular failure
with normal inferior wall motion de-
spite the major perfusion of inferior
segment by the right coronary artery.
Preoperative echocardiography
showed onlymild right ventricular dys-
function before surgery. There was no
ST elevation on electrocardiographic
monitoring. Finally, the patient under-
went bypass grafting of the saphenous
vein to the right coronary artery with
possibility of right coronary artery
obstruction. Interestingly, she was suc-
cessfully separated from the cardiopul-
monary bypass pump, and shewaswell
during hospital stay. The follow-up cor-
onary computed tomographic angiog-
raphy showed obstruction of the
right coronary artery ostium by me-
chanical prostheses. She was dis-
charged, and her midterm follow-up
was uneventful.
When right ventricular failure oc-
curs during aortic valvular operation,
inadequate myocardial protection
may be the culprit. Other causes of
right ventricular failure should be con-
sidered, such as air or particulate mat-
ter embolization. Right ventricular
failure that unexpectedly occurs dur-
ing an aortic valvular operation most
probablywould be due to amechanical
problem with the right coronary
ostium.2-5
We concluded that when right ven-
tricular failure unexpectedly occurs
during an aortic valvular operation
and does not improvewith reperfusion
and auxiliary medications, a mechani-
cal problem in the right coronary
artery should be considered even
with normal motion in inferior wall
and normal findings on electrocardio-
graphic monitoring. This rare compli-
cation could be life threatening if not
promptly recognized. Consequently,
it is important to have an high index
of diagnostic suspicion. Rescue coro-
nary artery bypass grafting in this
situation would be lifesaving.12
